PerkinElmer Buys EUROIMMUN for $1.3 Billion

by | Jun 19, 2017 8:37 pm | Laboratories, MRI & Dialysis | 0 comments

Mergers and acquisitions in the Laboratories, MRI and Dialysis sector increased nearly 30% through late June, compared with the same time last year. Fourteen acquirers inked 22 acquisitions, and most of the deal making was done by publicly traded companies, with financial buyers only accounting for four of the deals. PerkinElmer, Inc. (NYSE: PKI) has been involved in several deals as a result of undergoing some business changes. The company traded in its medical imaging business to bolster a stronger position in diagnostic screening in several global regions, with an emphasis on infectious diseases. Late in December 2016, it announced the divestiture of its Medical Imaging business, a... Read More »
Varian Spins Off Varex Imaging Systems

Varian Spins Off Varex Imaging Systems

by | Feb 3, 2017 5:25 pm | Laboratories, MRI & Dialysis | 0 comments

A medical imaging company is born. Or, rather, another medical imaging company goes public. Varian Medical Systems Inc. (NYSE: VAR) paid $276 million for the medical imaging business of PerkinElmer (NYSE: PKI) back in December 2016. That business, based in Santa Clara, California, supplies flat panel x-ray detectors that serve as components for industrial, medical and dental x-ray imaging systems. That deal was part of Varian’s plan to spin off its Imaging Components business. That feat was accomplished in January 2017, with the launch of Varex Imaging Corporation (NASDAQ: VREX), with a market cap of $1.09 billion. Under the terms of the separation, Varian stockholders received 0.4... Read More »

December 2016 Didn’t Deliver a Year-End Boost

by | Jan 13, 2017 4:37 pm | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Medical Devices, Pharmaceuticals, Physician Medical Groups, Private Equity, Rehabilitation | 0 comments

The final month of the fourth quarter is typically a busy one for deal makers in all industries. Last year, some health care deal makers apparently got a rest. Deal volume in December 2016 was an anemic 119 transactions, compared with 131 deals in November and 148 in December 2015. The Services sectors accounted for 55% of the deals in December, which is on the low side. Consider that, in November, Services accounted for 69% of the month’s transactions, and even 70% of the total in December 2015. Spending on those deals reached $15.4 billion, a relatively modest amount until it is compared with November’s $8.7 billion total (+78%) and December 2015’s $12.3 billion total (+26%). Suddenly,... Read More »